MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Heatmap
  • Русский
  • 中文
  • Español
  • Português
  • 日本語
  • Deutsch
  • 한국어
  • Français
  • Italiano
  • Türkçe
Cadrenal Therapeutics, Inc. Common Stock

CVKD

#4817
Cadrenal Therapeutics, Inc. Common Stock
4.79 USD
-4.01%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
4.79
4.79
Year Range
4.21
8.96
Daily Change
-4.01%
Monthly Change
-35.53%
6 month change
-13.22%
Year Change
-13.22%
Previous Close
4.99
Open
4.79
Bid
Ask
Low
4.79
High
4.79
Volume
2
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. CVKD
Open full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 12.01 M
  • Employee 5
  • Founded 2022
  • CEO N/A
  • Website www.cadrenal.com
  • Headquarter Delaware, United States
  • FIGI BBG019STRT20
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
12.01 M Market capitalization
Price to earnings ratio
-1.02
Price to sales ratio
—
Dividends per share
16.5
Dividend yield %
243.36

News

Investing Investing
CVKD
2026.03.02
Cadrenal schedules FDA meeting for HIT drug CAD-1005
Investing Investing
CVKD
2026.02.24
Cadrenal Therapeutics stock surges on Phase 2 trial results
Investing Investing
CVKD
2026.02.24
Cadrenal’s CAD-1005 shows reduction in blood clots in HIT trial
Investing Investing
CVKD
2026.01.12
Cadrenal highlights potential of 12-LOX inhibitor for blood disorder
Investing Investing
CVKD
2025.12.11
Cadrenal Therapeutics acquires first-in-class HIT treatment from Veralox
Investing Investing
CVKD
2025.12.01
Cadrenal Therapeutics appoints PTC Therapeutics CMO to board
Zacks Zacks
CVKD
2025.11.08
Cadrenal Therapeutics, Inc.
Zacks Zacks
CVKD
2025.11.08
Cadrenal Therapeutics, Inc.
Investing Investing
CVKD
2025.10.08
Cadrenal therapeutics CFO Szot sells $1496 in shares
Investing Investing
CVKD
2025.09.27
Szot, CFO of Cadrenal, sells $174k in CVKD stock
Investing Investing
CVKD
2025.09.27
Cadrenal therapeutics (CVKD) CEO Pham sells $131,779 in stock
Investing Investing
CVKD
2025.09.15
Cadrenal Therapeutics acquires eXIthera’s anticoagulant portfolio

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
Scan to install from App Store
Scan to install from Google Play
Scan to install from Huawei AppGallery
Scan to install APK
MQL5 Channels
Scan to install from App Store
Scan to install from Google Play
Scan to install from Huawei AppGallery
Scan to install APK
Economic Calendar
Scan to install from App Store
Scan to install from Google Play
Scan to install from Huawei AppGallery
Scan to install APK
Risk Disclosure Terms of Use Help Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd